B. Selected peer-reviewed publications (in chronological order).
*** Selected from over 170 peer-reviewed articles

	Sorenson CA, Swerdlow NR. The effects of tail pinch on the acoustic startle response in rats. Brain Res 247,105-113, 1982.
	Swerdlow NR, Koob GF. Separate neural substrates of amphetamine-, caffeine-, and CRF-stimulated locomotor activation. Pharmacol Biochem Behav 23, 303-307, 1985.
	Swerdlow NR, Geyer MA, Braff DL, Koob GF. Central dopamine hyperactivity in rats mimics abnormal acoustic startle in schizophrenics. Biol Psychiatry 21:23-33, 1986.
	Swerdlow NR, Vaccarino F, Amalric M, Koob G. Neural substrates for the motor-activating properties of psychostimulants: A review of recent findings. Pharmacol Biochem Behav 25:233-248, 1986.
	Swerdlow NR, Koob GF. Dopamine, schizophrenia, mania and depression: Toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav Brain Sci 10, 197-245, 1987.
	Swerdlow NR, Geyer M, Mansbach R, Braff D, Pulvirenti L. Amphetamine disrupts prepulse inhibition of acou-stic startle in rats: Reversal by nucleus accumbens dopamine lesion. Psychopharm 100:413-416, 1990.
	Swerdlow NR, Masten V, Geyer MA, Braff DL. Schizophrenic-like abnormalities in sensory gating following accumbens dopamine infusions in rats. Psychopharm 101: 414-420, 1990.
	Swerdlow NR, Keith V, Braff DL et al. Effects of spiperone, raclopride, SCH23390 and clozapine on apomor-phine inhibition of sensorimotor gating of the startle response in the rat. J Pharm Exp Ther 256:530-6, 1991.
	Swerdlow NR, Caine SB, Braff DL, Geyer MA. Neural substrates of sensorimotor gating of the startle reflex: Preclinical findings and their implications. J Psychopharmacol 6: 176-190, 1992.
	Swerdlow NR, Geyer MA. Prepulse inhibition of acoustic startle in rats after lesions of the pedunculopontine nucleus. Behav Neurosci 107: 104-117, 1993.
	Swerdlow NR, Braff DL, Taaid N, Geyer MA. Assessing the validity of an animal model of sensorimotor gating deficits in schizophrenic patients. Arch Gen Psychiatry 51:139-154, 1994.
	Swerdlow NR, Lipska BK, Weinberger DR, Braff DL, Jaskiw GE, Geyer MA. Increased sensitivity to the gating-disruptive effects of apomorphine after lesions of the medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharm 122: 27-34, 1995.
	Wan FJ, Geyer MA, Swerdlow NR. Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating. Psychopharm 120: 433-441, 1995.
	Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR. Impaired prepulse inhibition of acous-tic and tactile startle in patients with Huntington's Disease. J Neurol Neurosurg Psychiat 58: 192-200, 1995.
	Swerdlow NR, Braff DL, Hartston H et al.. Latent inhibition in schizophrenia. Schiz Res 20: 91-103, 1996.
	Swerdlow NR, Magulac M, Filion D, Zinner S. Visuospatial priming and latent inhibition in children and adults with Tourette’s Disorder. Neuropsychology 10: 485-494, 1996.
	Swerdlow NR, Bakshi V, Geyer MA. Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharm Exp Ther 279: 1290-1299, 1996.
	Wan FJ, Swerdlow NR. The basolateral amygdala regulates sensorimotor gating of acoustic startle in rats. Neuroscience 76: 715-724, 1996.
	Wan FJ, Caine SB, Swerdlow NR. The ventral subiculum modulation of prepulse inhibition is not mediated via D2 dopamine or nucleus accumbens non-NMDA glutamate activity. Eur J Pharmacol 314: 9-18, 1996.
	Wan FJ, Swerdlow NR. Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Res 722: 168-176, 1996.
	Kodsi MH, Swerdlow NR. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington’s Disease. Neurosci Lett 231: 1-5, 1997.
	Kodsi MH, Swerdlow NR. Regulation of sensorimotor gating by pallidal efferent projections. Brain Res Bull 43: 219-228, 1997.
	Swerdlow NR, Braff DL, Geyer MA. Animal models of deficient sensorimotor gating: What we know, what we think we know, and what we hope to know soon. Behav Pharmacol 111:185-204, 2000.
	Swerdlow NR, Taaid N, Halim N, Randolph E, Kim YK, Auerbach P. Hippocampal lesions enhance startle gating-disruptive effects of apomorphine in rats: A parametric assessment. Neuroscience 96:523-536, 2000.
	Halim ND, Swerdlow NR. Distributed neurodegenerative changes 2 - 28 days after ventral hippocampal excitotoxic lesions in rats. Brain Research 873:60-74, 2000.
	Swerdlow NR, Martinez ZA, Hanlon FM et al. Towards understanding the biology of a complex phenotype: Rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neuroscience 20:4325-4326, 2000.
	Swerdlow NR, Hanlon FM, Henning L, Kim YK, Gaudet I, Halim ND Regulation of sensorimotor gating in rats by hippocampal NMDA: Anatomical localization. Brain Res 898: 195-203, 2001.
	Swerdlow NR, Geyer MA, Braff DL. Neural circuitry of prepulse inhibition of startle in the rat: Current knowledge and future challenges. Psychopharm 156:194-215, 2001.
	Swerdlow NR, Shoemaker JM, Pitcher L et al. Genetic differences in startle gating-disruptive effects of apomorphine: Evidence for central mediation. Behav Neurosci 116: 682-690, 2002.
	Swerdlow NR, Leckman JF. Tourette Syndrome and related tic disorders. Fifth Generation of Progress, ACNP (Lippincott, Williams & Wilkins, Baltimore), pp. 1685-1698, 2002.
	Swerdlow NR, Shoemaker J, Stephany N, Wasserman L, Ro HJ, Geyer MA. Prestimulus effects on startle magnitude: Sensory or motor? Behavioral Neurosci 116: 672-681, 2002.
	Swerdlow NR, Pitcher L, Noh HR, Shoemaker JM. Startle gating in rats is disrupted by chemical inactivation but not D2 stimulation of the dorsomedial thalamus. Brain Research 953: 246-254, 2003.
	Swerdlow NR, Stephany N, Wasserman LC, et al. Amphetamine effects on prepulse inhibition across species: Replication and parametric extension. Neuropsychopharm 28: 640-650, 2003.
	Swerdlow NR, Shoemaker JM, Noh HR, Ma L, Gaudet I, Munson M, Crain S, Auerbach PP. The ventral hippocampal regulation of prepulse inhibition and its disruption by apomorphine in rats are not mediated via the fornix. Neuroscience 123:675-85: 2004.
	Swerdlow NR, Shoemaker JM, Platten A, Pitcher L, Goins J, Auerbach PP. Heritable differences in the dopaminergic regulation of sensorimotor gating: I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny. Psychopharm 174: 441-451, 2004.
	Swerdlow NR, Shoemaker JM, Auerbach PP, Pitcher L, Goins J, Platten A. Heritable differences in the dopaminergic regulation of sensorimotor gating: II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition. Psychopharm 174: 452-462, 2004.
	Swerdlow NR, Kuczenski R, Goins JC, Crain SK, Ma LT, Bongiovanni M, Shoemaker JM. Neurochemical analysis of rat strain differences in the startle gating-disruptive effects of dopamine agonists. Pharmacol Biochem Behav 80: 203-211, 2005.
	Shoemaker JM, Saint Marie RL, Bongiovanni MJ, Neary AC, Tochen LS, Swerdlow NR. Prefrontal D1 and ventral hippocampal NMDA regulation of startle gating in rats. Neuroscience (in press) 2005.
	Swerdlow NR, Geyer MA, Shoemaker JM, Light GA, Braff DL, Stevens KE, Sharp R, Breier B, Neary A, Auerbach PP. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology (in press) 2005.